Western medicine overwhelmingly uses pharmaceuticals to treat both chronic and non-chronic health conditions. In the case of diabetes, pharmaceuticals have completely failed to prevent or cure the disease.
The pharmaceutical industry produces and heavily promotes killer drugs like Avandia. This drug was introduced in 1999 and promoted with a nationwide ad campaign as the modern solution to diabetes. Avandia’s annual revenue EXPLODED to 3.2 billion dollars in just six years. But don’t be fooled, It’s a killer!
The New England Journal of Medicine was the first to blow the whistle on Avandia, exposing it as a killer. The journal linked the drug to a 43 percent increased risk of heart attack and a 64 percent increased risk of cardiovascular death.
When the dust finally settled from the news, 50,000 lawsuits were filed against GlaxoSmithKline (GSK), the maker of Avandia, for its contribution to 100,000 heart attacks. The lawsuits were settled in 2013 when GSK agreed to pay $229 million. GSK denied any wrong-doing and the FDA never banned the drug from sale or use.
Today, GlaxoSmithKline uses warning labels to remind doctors and tell patients that Avandia “can cause fluid retention, which may exacerbate or lead to heart failure.” The fluid retention issues also mean “Avandia should be used with caution in patients with edema,” and fluid retention may be a cause of weight gain among patients taking Avandia. The makers also warn of “an increased incidence of bone fracture in patients, particularly female patients.”
Avandia is a member of the class of medications called thiazolidinediones (TZD) or glitazones, which also includes Rezulin (troglitazone) and Actos (pioglitazone). Glitazones are known as “insulin sensitizers” because they make type 2 diabetes patients more sensitive to insulin, helping them to better maintain safe glucose levels.
All three drugs in the TZD family have had problems. Actos has been linked to an increased risk of heart failure and bladder cancer, but has not been recalled. The FDA approved Rezulin in 1997 but banned the drug in 2000 after it was shown to cause liver damage. Avandia use was severely restricted by the FDA in 2010, but it removed the restrictions in 2013, saying in a statement, “Although some scientific uncertainty about the cardiovascular safety of rosiglitazone medicines still remains, in light of the new re-evaluation of the Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycemia in Diabetes (RECORD) trial, our concern is substantially reduced.”
For the RECORD, BloodSugarBasics.com believes that all TZD drugs should be banned by the FDA.
Avandia, like all TZDs, works by making patients more sensitive to their own insulin. It’s designed to lower blood sugar by increasing the sensitivity of muscle, fat and liver cells to insulin.
However, as we now know, diabetes is not a disease of blood sugar. Avandia, and drugs like it, treat the symptom, not the underlying cause. This is inherently dangerous as a long-term treatment.
IMPORTANT: As I reported in the first part of this article series, I put my prediabetes in full remission without the use of drugs. I did this by changing my eating habits, my diet, and my exercise. I didn’t make any radical changes. I simply refused to give in to what the pharmaceutical companies are selling , which in my estimation is nothing more than an easy way out.
CRITICAL: If you want to take the easy way out, DO NOT click on 7 Steps to Life without Type 2 Diabetes because it will be a waste of your time. Instead, continue to live at the edge of death, comfortable in the knowledge that the medications you have been prescribed will help delay heart disease, stroke, pulmonary artery disease, blindness, and amputations.
The commentary on BloodSugarBasics.com is meant to supplement your knowledge of type 2 diabetes, its cause, and healthy lifestyle changes that can lead to recovery. All diabetic patients should follow the professional medical advice of their healthcare team, including nutrition, physical activity, testing and medication.